Myelodysplastic/myeloproliferative Disease - 7 Studies Found
Recruiting |
: A Phase 1 Study Evaluating CPI-0610 in Patients With Acute Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasms, and Myelofibrosis :
: Drug: CPI-0610 |
Completed |
: Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes :
|
Completed |
: Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome :
|
Completed |
: Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia :
|
Completed |
: Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS :
|
Completed |
: Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer :
|
Completed |
: Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome :
|